AbbVie Says Canada's Drug Agency Recommends UBRELVY Be Reimbursed With Conditions By Public Drug Plans For Acute Treatment Of Migraine In Adults

뉴스 본문을 불러오고 있어요.

AbbVie Says Canada's Drug Agency Recommends UBRELVY Be Reimbursed With Conditions By Public Drug Plans For Acute Treatment Of Migraine In Adults | 웨이프 WAPE

AbbVie Says Canada's Drug Agency Recommends UBRELVY Be Reimbursed With Conditions By Public Drug Plans For Acute Treatment Of Migraine In Adults

기사 요약

관련 종목

댓글 —